Reetu Mukherji, MD| Gastrointestinal Medical Oncology, Hematology Oncology | MedStar Health
Reetu Mukherji

Reetu Mukherji, MD
Provider is directly employed by MedStar Health

5 out of 5 (34 reviews)

Specialties: Gastrointestinal Medical Oncology, Hematology Oncology

Languages: English

About me

Reetu Mukherji, MD, is a fellowship-trained medical oncologist. She specializes in management of gastrointestinal malignancies, including esophagus, stomach, small bowel, colon, rectum, anal, pancreatic, and hepatobiliary cancers. Dr. Mukherji leads the medical oncology department’s clinical and research focus on upper gastrointestinal malignancies, including esophageal and gastric cancers.

She earned her medical degree from Temple University School of Medicine and completed her residency at Thomas Jefferson University Hospital, both of which are located in Philadelphia. Dr. Mukherji completed a fellowship in hematology/oncology at MedStar Georgetown University Hospital.

Dr. Mukherji has published in several peer-reviewed journals, including Current Treatment Options in Oncology and Journal of Clinical Oncology, on the role of immunotherapies, applications of prognostic genomic biomarkers, and applications of liquid biopsies in the management of patients with gastrointestinal malignancies. She has also designed investigator-initiated clinical trials studying emerging blood-based biomarkers like circulating tumor DNA and testing novel therapies across gastrointestinal cancers. Her research includes collaboration with basic scientists to study circulating tumor cells from liquid biopsies. 

She is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the American Medical Association.

About MedStar Georgetown Cancer Institute
MedStar Georgetown is part of the MedStar Georgetown Cancer Institute, which combines medical expertise, the latest therapies, and research across MedStar Health. Our research engine, the Georgetown Lombardi Comprehensive Cancer Center, is the only National Cancer Institute-designated comprehensive cancer center in the Washington, D.C., region. This partnership means we provide access to cutting-edge clinical trials and the latest breakthroughs in cancer care.

Dr. Mukherji’s philosophy of care
Dr. Mukherji is committed to approaching each patient comprehensively and with respect. She understands a cancer diagnosis is life-changing for patients and values educating them on their complex disease and management strategies in order to make informed decisions together in their best interest. She strongly believes in the value of working collaboratively with patients, their support systems, and multi-disciplinary teams to deliver the highest level of care and support through their cancer diagnosis.

Clinical areas of focus

  • Colorectal Malignancy
  • Esophageal Cancer
  • Pancreas Cancer
  • Rectal Cancer
  • Stomach Cancer
Show More

Conditions and procedures

Conditions I treat

  • Abdominal Cancer
  • Anal Cancer
  • Appendiceal Cancer
  • Bile Duct Mass
  • Cancer
  • Cancer During Pregnancy
  • Cancer Pain
  • Cancer Related Fatigue
  • Cancer Survivor
  • Cholangiocarcinoma
  • Colorectal Malignancy
  • Cowden Syndrome
  • Esophageal Cancer
  • Gallbladder Cancer
  • Gastroesophageal Junction Cancer
  • Gastrointestinal (GI) Cancer
  • Gastrointestinal (GI) Stromal Tumors
  • Head And Neck Tumors
  • Hereditary Cancer Risk
  • Liver Cancer
  • Liver Metastases
  • Malignant Carcinoid Tumor Of Colon
  • Pancreas Cancer
  • Peutz Jeghers Syndrome
  • Rectal Cancer
  • Side Effects Of Cancer Treatment
  • Small Intestine Cancer
  • Stomach Cancer
Show All Show Less

Procedures I perform

  • Adjuvant Chemotherapy
  • Anticoagulation
  • Biological Targeted Therapy
  • Bone Marrow Biopsy
  • Cancer Chemotherapy
  • Cancer Genomics
  • Cancer Immunotherapy
  • Chemoradiation
  • Colon Cancer Chemotherapy
  • Colon Cancer Genomics
  • Early Detection Of Cancer
  • Esophageal Cancer Chemotherapy
  • Gallbladder Cancer Chemotherapy
  • Gallbladder Cancer Genomics
  • Gastrointestinal (GI) Cancer Genomics
  • Liver Cancer Genomics
  • Pancreatic Cancer Chemotherapy
  • Pancreatic Cancer Genomics
  • Rectal Cancer Genomics
  • Small Intestine Cancer Chemotherapy
  • Stomach Cancer Chemotherapy
  • Stomach Cancer Genomics
Show All button Press enter to expand Show Less

Practice locations

Distance from Change LocationEnter your Location

3800 Reservoir Road Northwest
Washington, DC, 20007


Fax 877-346-1469

Get Directions

miles away

Fax 877-346-1469


MedStar Health accepts most major health insurance plans. If you are uncertain as to whether your individual health insurance plan is accepted at MedStar Health, please call your insurance company.

  • List of insurance plans we accept
    • United Navigate
    • Carefirst Blue Preferred PPO
    • Kaiser Signature
    • Private Health Care Systems (PHCS) (PPO)
    • CareFirst (NCA) Indemnity
    • CareFirst NASCO
    • Kaiser Maryland Medicaid MCO
    • Carefirst BlueChoice HMO
    • CareFirst Maryland Indemnity or PPO
    • Veterans Affairs Community Care Network (VA CCN)
    • Kaiser Medicare Plus
    • United Group Medicare Advantage Plans
    • United Select HMO - EPO/NPP
    • CareFirst Group Medicare Advantage
    • Carefirst Healthy Blue (HMO/POS)
    • Innovation Health: Open POS II
    • Police and Fire Clinic
    • Carefirst BlueChoice Opt Out Open Access
    • Aetna Managed Choice Open Access (POS)
    • United MD IPA (HMO)
    • Innovation Health: HMO & EPO Plus
    • CareFirst Administrators
    • Aetna Select HMO/HealthFund/Health Network
    • United Medicare Advantage DSNP District of Columbia
    • Innovation Health: PPO
    • Aetna Open HMO/Open HMO Option/Open EPO Plus
    • Cigna HMO & Network (HMO)
    • Aetna HMO
    • CareFirst BC/BS Advantage Core/Enhanced
    • United Choice Plus
    • Cigna PPO and PPO Plus
    • Carefirst BlueChoice Open Access
    • CareFirst Group Medicare Advantage prescription drug benefit (PPO)
    • Innovation Health: Open Network Only Plus
    • United MD IPA Preferred (POS)
    • Aetna HealthFund/Health Network Option OA
    • Innovation Health: Indemnity
    • United Options (PPO) (includes Empire PPO)
    • Innovation Health: Open POS Plus
    • Carefirst BlueChoice Opt Out Plus Open Access (POS)
    • Aetna Elect Choice/ Open Access (POS)
    • Kaiser HMO Plus and DHMO Plus Member
    • Cigna HMO Open Access
    • Aetna Managed Choice (POS)
    • Innovation Health: Network Only Plus
    • Choice Care Network/HUMANA (PPO)
    • Tricare East Prime
    • Aetna Elect Choice/ EPO (Aetna Health Fund)
    • D-SNP)
    • Kaiser Medicare Advantage Signature and Select
    • I-SNP
    • Cigna POS Open Access & Open Access Plus
    • United GEHA (for all other states) Compass Rose
    • Cigna True Choice Plus Medicare (PPO)
    • Tricare East Select
    • Aetna Medicare Advantage HMO & PPO Plans
    • United Choice
    • Beech Street PPO
    • United Core Essential (HMO)
    • CareFirst MedStar PPO
    • United Nursing Home Plan (C-SNP
    • Medicaid - Maryland
    • Cigna Alliance Medicare (HMO) |
    • MedStar Family Choice DC Healthcare Alliance
    • Kaiser Flexible Choice
    • Kaiser Select
    • Anthem HMO - BCBS of VA HealthKeepers
    • HumanaChoice PPO
    • Cigna True Choice Medicare (PPO)
    • United Erickson Advantage Plans
    • United Golden Rule
    • Tricare Reserve Select
    • Aetna HMO-Open Access/Select OA
    • Cigna Indemnity
    • Tricare for Life East
    • Cigna POS/Network POS
    • Aetna Choice POS & Choice POS II
    • CareFirst Blue Card Program (Out-of-area BCBS plans)
    • Cigna Network Open Access
    • Kaiser Permanente Signature-Added Choice
    • Cigna Achieve Medicare (HMO C-SNP)
    • WellPoint Maryland - Maryland Health Choice
    • Aetna Open Choice (PPO)
    • Veterans Affairs Community Care Network
    • United Optimum Choice
    • Cigna Preferred Medicare
    • HealthyBlue PPO
    • United Mamsi Life & Health
    • United Student Resources
    • Anthem Plus BCBS of VA HealthKeepers Plus
    • Aetna Quality Point of Service (POS)
    • Innovation Health: POS Plus
    • Aetna Student Health Insurance
    • Federal Employee Program (Std/Basic PPO/Blue Focus)
    • United Community Plan - Maryland Health Choice Program
    • Aetna Signature Administrator PPO/TPA
    • United AARP Medicare Complete
    • Medicaid - Virginia
    • CareFirst MedStar Select PPO
    • Kaiser Select-Added Choice
    • United Optimum Choice Preferred (POS) & OCI Direct (HMO)
    • Anthem (POS & Open Access POS) BCBS of VA HealthKeepers
    • Health Services for Children with Special Needs (HSCSN)
    • HumanaChoice Honor’s plan PPO
    • UnitedHealthcare Individual Exchange Plans
    • Traditional Medicare Fee for Service
    • Maryland Point of Service Plan (MPOS)
    • Cigna TotalCare (HMO D-SNP)
    • Virginia Premier
    • Aetna Traditional Choice (PPO)
    • WellPoint Maryland
    • Medicaid - District of Columbia
    • MedStar Family Choice DC Healthy Families
    • Innovation Health: POS
    • United Select Plus (POS)
    • Cigna Choice Fund PPO
    • Cigna EPO
    • Carefirst EPO
    • MedStar Family Choice - Maryland Health Choice
    • First Health PPO
    • Coventry of Delaware HMO/PPO
    • Coventry Health Care of Virginia
    • Coventry Health Care National Network PPO
    • Great-West Healthcare POS/CIGNA



Board Certification: American Board of Internal Medicine, Internal Medicine

Board Certification: American Board of Internal Medicine, Hematology

Board Certification: American Board of Internal Medicine, Medical Oncology

Fellowship Program: MedStar Georgetown University Hospital (2022)

Residency Program: Sidney Kimmel Medical College (2019)

Medical School: Temple University School of Medicine (2016)

News and publications

  1. Mukherji R, Debnath D, Hartley M, Noel M. The Role of Immunotherapy in Pancreatic Cancer. Current Oncology. 2022; 29(10):6865-6892. doi: 10.3390/curroncol29100541
  2. Mukherji R, Yin C, Hammed R, Alqahtani A, Kulsekaran M, He A, Weinberg B, Marshall J, Hartley M, Noel M. The Current State of Molecular Profiling in Gastrointestinal Malignancies. Biology Direct. 2022; 18:15.
  3. Mukherji R, Alqahtani A, Winters H, Weinberg B. Use of Circulating Tumor DNA to Assess Minimal Residual Disease in Gastrointestinal Cancers. touchREVIEWS in Oncology & Haematology. 2022; 18(1): Online ahead of journal publication.
  4. Mukherji R, Weinberg B, Pedersen K. Immunotherapy for Colorectal Cancer. Hematology/Oncology Clinics of Northern America. 2022; 36(3): 603-626. doi 10.1016/j.hoc.2022.02.010.
  5. Mukherji R, Marshall J.  Lessons Learned in Managing Patients with Colorectal Cancer During the Covid-19 Pandemic.  Current Treatment Options in Oncology. 2021; 22(10):93. doi: 10.1007/s11864-021-00888-3.
  6. Mukherji R, Weinberg B.  The Gut Microbiome and Potential Implications for Early-Onset Colorectal Cancer.  Colorectal Cancer. 2020; 9(3). doi: 10.2217/crc-2020-0007.
  7. Mukherji R, Marshall J, Seeber A.  Genomic Alterations and Their Implications on Survival in Nonmetastatic Colorectal Cancer: Status Quo and Future Perspectives.  Cancers (Basel). 2020; 12(8): 2001. doi: 10.3390/cancers12082001
  8. Johnson W, Mukherji R, Kartan S, Nikbakht N, Porcu P, Alpdogan O.  Allogenic Hematopoietic Stem Cell Transplantation in Advanced Stage Mycosis Fungoides and Sezary Syndrome: A Concise Review.  Chinese Clinical Oncology. 2019; 8(1):12. doi 10.21037/cco.2018.10.03.
  9. Jain R, Savage M, Forman AD, Mukherji R, Hall, M. The Relevance of Hereditary Cancer Risks to Precision Oncology: What Should Providers Consider When Conducting Tumor Genomic Profiling. Journal of the National Comprehensive Cancer Network. 2016;14(6): 795-806. doi:10.6004/jnccn.2016.0080.
  1. Mukherji R, Yin C, Weinberg B, Alqahtani A, Hameed R, Barcellos A, Connole M, Pereigut C, Fortuin J, Marshall J.  Continuous maintenance (Maint) capecitabine (Cape) dosing for colorectal (CRC) and pancreatic cancers (PC): A single-institution, retrospective, real-world study.  Poster accepted for presentation at 2023 GI ASCO; Jan 19-21, 2023; San Francisco, California, USA.
  2. Mukherji R, Suguru S, Xiao J, Geng X, Wang H, Noel M, He A, Weinberg B, Marshall J, Agarwal S.  Success rates and clinicopathologic associations with experimental outcomes of a novel circulating tumor cell (CTC) technology in advanced colon cancer (CC) and pancreatic cancer (PC). Poster accepted for presentation at 2023 GI ASCO; Jan 19-21, 2023; San Francisco, California, USA.
  3. Mukherji R, Boudriga A, Isenstein H, Marshall J. Establishing the feasibility of a patient-engagement tool to improve outpatient symptom management and dosing of patients on regorafenib. Poster presented at 2022 ASCO Quality Care Symposium; Oct 1, 2022; Chicago, IL, USA.
  4. Debnath D, Nair N, Mukherji R, Marshall J. A rare case of recurrent metastatic neuroendocrine adenoma of the middle ear. Poster presented at 2022 DC American College of Physicians Scientific Meeting; May 21, 2022; Washington, District of Columbia, USA.
  5. Alqahtani A, Alloghbi A, Yin C, Mukherji R, Weinberg B.  Prognostic utility of preoperative and postoperative circulating tumor DNA (ctDNA) in resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.  Poster presented at 2022 GI ASCO; Jan 20-22, 2022; San Francisco, California, USA.
  6. Bauml J, Mick R, McCoach C, Weiss J, Marrone K, Nieva J, Villaruz L, Levy B, Moreno R, Mukherji R, Sun F, Schwartzman W, Shaverdashvili K, Wang X, Shah M, Woodley J, Miller N, Succe C, Ullah T, Lovly C, Doebele R, Iams W, Horn L, Dowell J, Liu G, Leighl N, Patil T, Liu S, Velcheti V, Aisner D, Camidge R. Multicenter Analysis of Mechanisms of Resistance to Osimertinib (O) in EGFR Mutated NSCLC: An ATOMIC Registry Study. Poster presented at: 2020 World Conference on Lung Cancer; Jan 28-31, 2021; Singapore. 
  7. Shah R, Ellingsen H, Halloran M, Mukherji R, Kloo J, Lev Y.  Get With the Rhythm- Telemetry Education in Internal Medicine Residency.  Poster presented at: The Annual House Staff Quality Improvement and Patient Safety Poster Session; June 2018; Philadelphia, PA, USA.
  8. Kaczmar J, Gustafom K, Wong Y, Mukherji R, Minniti C, Sandilya V, Sprandio J, Chertock Y, Hart C, Hall M.  Tumor genomic profiling (TGP) in metastatic colorectal cancer (CRC): Bridging the community and the tertiary cancer center through genomic consultation (GC).  Poster Presented at: 2016 ASCO Annual Meeting; June 3-7; Chicago, IL, USA. 
  9. Dave H, Mukherji R, Johnson S, Williams D, Jacobsohn D, Bollard C, Williams K.  Voriconazole Levels Indicate That Pediatric Prophylaxis Dosing May be Insufficient.  Poster Presented at: Biology of Blood and Marrow Transplantation ASPHO 2015 Annual Meeting; May 6-8, 2015; Washington, D.C.
  10. Gautam J, Gevaria A, Mukherji R, Bolton K.  T Cell Epitope Spreading In Experimental Autoimmune Glomerulonephritis (EAG) In Rats.  Poster presented at: ASN Kidney Week 2013 Annual Meeting; Nov 5-10, 2013; Atlanta, GA.

Ratings and reviews

  • Explanations the care provider gave you about your problem or condition

  • Extent to which the care provider listened to you

  • Care provider’s discussion of any proposed treatment (options, risks, benefits, etc.)

  • Care provider’s efforts to include you in decisions about your care

  • Concern the care provider showed for your questions or worries

  • Likelihood of recommending this care provider to others

  • Apr 22, 2024

    Dr. Mukherji is outstanding. She exhibits great listening skills, clearly cares, and is thorough.

  • Mar 28, 2024


  • Feb 9, 2024

    Dr. M. managed my care so that I may be able to enter a clinical trial. She is an exceptional communicator of info at an appropriate level of detail.